We are live on
!
Find out more
WA
Winfield Associates Portfolio holdings
AUM
$276M
1-Year Est. Return
15.18%
This Fund
S&P 500
This Quarter
Est. Return
+6.22%
1 Year Est. Return
+15.18%
3 Year Est. Return
+77.75%
5 Year Est. Return
+124.89%
10 Year Est. Return
–
AUM
$198M
AUM Growth
+$7.62M
(+4%)
Cap. Flow
-$3.55M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
880
New
61
Increased
161
Reduced
130
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$568K |
| 2 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$454K |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$397K |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$389K |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$343K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$920K |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$554K |
| 3 |
AT&T
T
|
+$446K |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$427K |
| 5 |
Cedar Fair
FUN
|
+$400K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.03% |
| 2 | Consumer Discretionary | 8.65% |
| 3 | Communication Services | 6.74% |
| 4 | Financials | 5.7% |
| 5 | Industrials | 4.76% |
Similar funds
SCM
ANRIA
PCA
LCP
FPOC
PWP
BHTS
KWP
Winfield Associates's Q4 2017 Portfolio in Review
As of Q4 2017, Winfield Associates held 880 positions worth $198M, up 4% from $190M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Winfield Associates's Q4 2017 filing shows 61 new, 161 increased, 130 reduced and 51 closed positions. Its largest new stake was iShares Core S&P Small-Cap ETF: 4,300 shares worth $331K. The largest sale was iShares Biotechnology ETF, an estimated $920K.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Winfield Associates's largest Q4 2017 buy was iShares Core S&P Small-Cap ETF: 4,300 shares worth $331K.
- Winfield Associates added most to State Street SPDR S&P Biotech ETF in Q4 2017, an estimated $568K increase.
- Winfield Associates's biggest Q4 2017 reduction was iShares Biotechnology ETF, cutting an estimated $920K.
- Winfield Associates fully exited NEW SENIOR INVESTMENT GROUP INC. in Q4 2017, selling an estimated $147K.
- Winfield Associates's ten largest holdings make up 31% of its $198M portfolio in Q4 2017.
- Winfield Associates opened 61 new positions and closed 51 in Q4 2017.
- Winfield Associates's portfolio value rose 4% quarter-over-quarter to $198M.
Based on Winfield Associates's 13F filing for Q4 2017, filed 12 Feb 2018.